Indications
Open Access TIMES Journals
Login
Register
Login
Register
Indications
Oncology · Hematology
Spine Surgery
Cardiovascular
Diabetes + Endocrinology
Pneumology
Ophthalmology
Gynecology · Urology
Dermatology · Immunology · Rheumatology
Neurology · Psychiatry
Gastroenterology
Infectiology · Anesthesiology · Pain
Primary Care
Open Access TIMES Journals
Oncology · Hematology
Spine Surgery
Cardiovascular
Diabetes + Endocrinology
Pneumology
Ophthalmology
Gynecology · Urology
Dermatology · Immunology · Rheumatology
Neurology · Psychiatry
Gastroenterology
Infectiology · Anesthesiology · Pain
Primary Care
Oncology · Hematology
Case Reports
Expert Opinions
Congress News
E-Learning
Webinar
Faculty
healthbook TIMES
Homepage
>
Oncology · Hematology
>
Articles
healthbook ASCO 2023 Newsroom
: Personal Highlights Dr Jason Westin
Share:
ASCO 2023
Related content
SABCS 2024
Breast Cancer
Advancing Breast Cancer Treatment with Elacestrant
Lymphoma
Real-World Direct Comparison Shows Superiority of Axi-Cel over Liso-Cel in Patients with R/R LBCL
SPECIAL REPORT
Breast Cancer
Managing Side Effects in Breast Cancer Treatment
SPECIAL REPORT
Breast Cancer
Advances in HER2-Negative Breast Cancer Treatment: Insights from the PRIMED study
Multiple Myeloma (MM)
Deep and Sustained Responses with Quadruplet Carfilzomib (Kyprolis
®
)-Based Regimens in Patients with NDMM
SPECIAL REPORT
Breast Cancer
Abémaciclib dans le cancer du sein HR-positif/HER2-négatif, avec atteinte ganglionnaire chez les femmes au stade précoce
SPECIAL REPORT
Breast Cancer
Abemaciclib beim HR-positiven/HER2-negativen, Lymphknoten-positiven Mammakarzinom bei Frauen im Frühstadium
Head and Neck Cancer
Transoral Robotic Surgery in the Multidisciplinary Care of Patients With Oropharyngeal Squamous Cell Carcinoma: ASCO Guideline
J Clin Oncol
Holsinger FC, Ismaila N, Adkins DR, Barber BR, Burnette G, Fakhry C, Galloway TJ, Goepfert RP, Miles BA, Paleri V, Patel AA, Roof SA, Starmer HM, Yom SS, Saba NF, Li R, Ku JA
doi: 10.1200/JCO-24-02755
EHA/ICML 2025
Lymphoma
Expanding the Curative Potential of CAR T-Cell Therapy
